Urology Times

Appreciation to Dr. Daniel Zainfeld for leading our recent Clinical Forum on high-risk NMIBC. The discussion covered key challenges and new approaches to treatment. Thanks to all who joined the conversation! Follow Urology Times® for more expert insights. #Urology #NMIBC

Andrea Pezzella, MD, URPS, FACOG, shares insights on the newly FDA-approved Neuspera integrated sacral neuromodulation device, highlighting its significance in the treatment of OAB and UUI. #urology urologytimes.com/view/andrea-pe…

Metastasis-directed radiotherapy without systemic therapy demonstrated promising efficacy with manageable safety in patients with oligometastatic ccRCC, according to phase 2 data presented at #KCRS25. urologytimes.com/view/metastasi…

WATCH📽️: Ashley Winter, MD, (@AshleyGWinter) reacts to the recent FDA panel discussion on menopausal hormone therapies, calling on the agency to revise the boxed warning label on low-dose vaginal estrogen. urologytimes.com/view/ashley-wi…

Three Aquablation procedures for prostate cancer have been successfully completed in an ambulatory surgery center as part of the WATER IV PCa Trial. @RahulMehan1 #pcsm urologytimes.com/view/aquablati…

In this @UrologyTimes video, @hjwang26 and @LauraBukavinaMD of @CleClinicUro discuss ctDNA's role in NMIBC treatment decisions. Click here to watch the video: urologytimes.com/view/betty-wan…

Joseph Song, MD, discusses the emergence of new suction-based technology for stone disease. @gaurology urologytimes.com/view/joseph-so…

Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES, discusses the strong connection between eating disorders and urinary incontinence in women. #urology urologytimes.com/view/how-eatin…

BREAKING 🚨: The #FDA has granted priority review to a supplemental application seeking expanded approval of flibanserin to treat hypoactive sexual desire disorder (#HSDD) in postmenopausal women. urologytimes.com/view/fda-grant…

Coding Q&A: Jonathan Rubenstein, MD, (@rubenstein_jn) and Mark Painter discuss when to report 50320 with 49187 for nephrectomy procedures. urologytimes.com/view/when-to-r…

The #FDA has granted 510(k) clearance to an updated version of the Philips UroNav System, which includes advanced annotation to enhance precision during focal therapy procedures for prostate cancer. #pcsm urologytimes.com/view/fda-clear…

A category III CPT code has been issued for Avvio Medical’s Enhanced Lithotripsy System for kidney stone treatment. #urology urologytimes.com/view/category-…

Video in @UrologyTimes: Optimizing NMIBC Treatment Through Sequencing and Patient Preference with @marktysonmd @BogdanaSchmidt Sheryas Joshi MD and co-authored by @tbivala1. Click to watch the video: urologytimes.com/view/current-s…

WATCH🎥: Daniel D. Joyce, MD, MS, discusses the economic and clinical considerations of using trimodal therapy vs radical cystectomy for patients with MIBC. @VUMCurology urologytimes.com/view/daniel-d-…

Watch Ziho Lee, MD (@ZLeeGU), highlight several key aspects and advancements attendees can expect at this years' Advances in Genitourinary Robotic Reconstruction course. @UrologyTimes @NUFeinbergMed urologytimes.com/view/ziho-lee-…

Data from the #PRESERVE trial have been published in European Urology, showing that IRE with the NanoKnife System was safe and effective for prostate tissue ablation in patients with intermediate-risk prostate cancer. #pcsm urologytimes.com/view/irreversi…

Sarah Razavi, MD, (@sarahmorazz) outlines strategies to mitigate fatigue and discomfort experienced by urologists performing flexible ureteroscopy. @wakeurology #urology urologytimes.com/view/sarah-raz…

Recent data suggest that water vapor therapy with Rezūm may be a more effective first-line treatment compared with pharmaceutical therapy for patients with BPH. #urology urologytimes.com/view/water-vap…